Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision label updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.1%
    Check dated 2026-03-11T16:16:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the study record history, and Revision: v3.4.1 was removed. This is a minor update to release notes and does not alter the study information.
    Difference
    0.9%
    Check dated 2026-02-11T11:10:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the site version updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:25:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI enhancements include a Show glossary option and color-coded highlights for additions (green) and deletions (red) in the record history. The revision banner now displays Revision: v3.4.0.
    Difference
    1%
    Check dated 2026-01-28T04:25:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (Revision: v3.3.4) replacing the prior version (v3.3.3) with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new revision entry: Revision: v3.3.3 to the Record History; removed the HHS Vulnerability Disclosure and the older Revision: v3.3.2 entry.
    Difference
    0.2%
    Check dated 2025-12-23T17:20:50.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.